DUNNE MICHAEL W. (Chief Scientific Officer) purchased 39.1% of their position (10K shares) of ITERUM THERAPEUTICS PLC on the open market
Open‑market purchase worth $22.2K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/9/2022ACC: 0001209191-22-049352
Officer· Chief Scientific Officer
Since Aug 2018
+10K
Net shares
Net buyer
$22.2K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
10K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+10K
Price / share
$2.22
Trade value
$22.20K
% of position
39.1%
9/7/2022
25.58K→35.58K
Total
Net shares
+10K
Net value
$22.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 9/7/2022 | P · Purchase | +10K | $2.22 | $22.20K | 39.1% | 25.58K | 35.58K |
| Total | +10K | $22.20K | ||||||
Derivative Transactions0
No derivative transactions reported